Abstract
Hepatocellular carcinoma is a major health problem worldwide. The prognosis of patients depends on the stage when the disease is diagnosed. For the early detection of these tumors, both the selection of patients at high risk and effective surveillance programs are important. When the tumor is diagnosed early, patients can choose potentially curative treatment, including surgical resection, transplantation, and ablation therapy. Here, we give an overview of the present management of hepatocellular carcinoma. Further studies in diagnosis, treatment, and prevention are required to achieve the best clinical management of this disease.
References
DM Parkin SL Whelan J Ferlay et al. (1997) Cancer incidence in five continents International Agency for Research on Cancer Lyon
SD Taylor-Robinson GR Foster S Arora et al. (1997) ArticleTitleIncrease in primary liver cancer in the UK, 1979–94 Lancet 350 1142–1143 Occurrence Handle9343506 Occurrence Handle1:STN:280:DyaK1c%2FgtlWjtA%3D%3D
HB El-Serag AC Mason (1999) ArticleTitleRising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745–750 Occurrence Handle10072408 Occurrence Handle1:STN:280:DyaK1M7ls1ensg%3D%3D Occurrence Handle10.1056/NEJM199903113401001
MP Coleman G Gatta A Verdecchia et al. (2003) ArticleTitleEUROCARE-3 summary: cancer survival in Europe at the end of the twentieth century Ann Oncol 14 IssueIDSuppl 5 v128–149 Occurrence Handle14684503
Ries LAG, Eisner MP, Kosary CL, et al. (2004) SEER cancer statistics review
R Tateishi H Yoshida S Shiina et al. (2004) ArticleTitleProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 419–425
H Yoshida Y Shiratori M Moriyama et al. (1999) ArticleTitleInterferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy Ann Intern Med 131 174–181 Occurrence Handle10428733 Occurrence Handle1:CAS:528:DyaK1MXlsVCrtbo%3D
H Yoshida R Tateishi Y Arakawa et al. (2004) ArticleTitleBenefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C Gut 53 425–430 Occurrence Handle14960528 Occurrence Handle1:CAS:528:DC%2BD2cXitlersLc%3D Occurrence Handle10.1136/gut.2003.030353
Y Shiratori Y Ito O Yokosuka et al. (2005) ArticleTitleAntiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 105–114 Occurrence Handle15657158 Occurrence Handle1:CAS:528:DC%2BD2MXktVequ74%3D
M Omata H Yoshida (2004) ArticleTitlePrevention and treatment of hepatocellular carcinoma Liver Transpl 10 S111–114 Occurrence Handle14762850 Occurrence Handle10.1002/lt.20046
R Tateishi S Shiina T Teratani et al. (2005) ArticleTitlePercutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 1201–1209 Occurrence Handle15690326 Occurrence Handle10.1002/cncr.20892
Y Koike Y Shiratori S Sato et al. (2000) ArticleTitleRisk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus – an analysis of 236 consecutive patients with a single lesion Hepatology 32 1216–1223 Occurrence Handle11093727 Occurrence Handle1:STN:280:DC%2BD3M%2FntFegsA%3D%3D Occurrence Handle10.1053/jhep.2000.20237
M Omata R Tateishi H Yoshida et al. (2004) ArticleTitleTreatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation Gastroenterology 127 S159–166 Occurrence Handle15508080 Occurrence Handle10.1053/j.gastro.2004.09.030
V Mazzaferro E Regalia R Doci et al. (1996) ArticleTitleLiver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693–699 Occurrence Handle8594428 Occurrence Handle1:STN:280:BymC2srhs1E%3D Occurrence Handle10.1056/NEJM199603143341104
H Bismuth L Chiche R Adam et al. (1993) ArticleTitleLiver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients Ann Surg 218 145–151 Occurrence Handle8393649 Occurrence Handle1:STN:280:ByyA2czmvVU%3D
T Takayama M Makuuchi S Hirohashi et al. (1998) ArticleTitleEarly hepatocellular carcinoma as an entity with a high rate of surgical cure Hepatology 28 1241–1246 Occurrence Handle9794907 Occurrence Handle1:STN:280:DyaK1M%2FhtlyqsQ%3D%3D
T Takayama M Makuuchi S Hirohashi et al. (1990) ArticleTitleMalignant transformation of adenomatous hyperplasia to hepatocellular carcinoma Lancet 336 1150–1153 Occurrence Handle1978027 Occurrence Handle1:STN:280:By6D2c7islA%3D Occurrence Handle10.1016/0140-6736(90)92768-D
M Kojiro T Roskams (2005) ArticleTitleEarly hepatocellular carcinoma and dysplastic nodules Semin Liver Dis 25 133–142 Occurrence Handle15918142 Occurrence Handle10.1055/s-2005-871193
M Sakamoto S Hirohashi Y Shimosato (1991) ArticleTitleEarly stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma Hum Pathol 22 172–178 Occurrence Handle1848205 Occurrence Handle1:STN:280:By6C287hsFQ%3D Occurrence Handle10.1016/0046-8177(91)90039-R
M Kojiro (2004) ArticleTitleFocus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view Liver Transpl 10 S3–8 Occurrence Handle14762831 Occurrence Handle10.1002/lt.20042
V Paradis I Bieche D Dargere et al. (2003) ArticleTitleMolecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index Am J Pathol 163 733–741 Occurrence Handle12875992 Occurrence Handle1:CAS:528:DC%2BD3sXmslSntr8%3D
FX Bosch J Ribes J Borras (1999) ArticleTitleEpidemiology of primary liver cancer Semin Liver Dis 19 271–285 Occurrence Handle10518307 Occurrence Handle1:STN:280:DyaK1Mvks1Gktw%3D%3D
XD Zhou ZY Tang BH Yang et al. (2001) ArticleTitleExperience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma Cancer 91 1479–1486 Occurrence Handle11301395 Occurrence Handle1:STN:280:DC%2BD3M3mtFCrsg%3D%3D Occurrence Handle10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0
MS Peterson RL Baron (2001) ArticleTitleRadiologic diagnosis of hepatocellular carcinoma Clin Liver Dis 5 123–144 Occurrence Handle11218911 Occurrence Handle1:STN:280:DC%2BD3M3gtlygsg%3D%3D Occurrence Handle10.1016/S1089-3261(05)70157-4
R Lencioni D Cioni C Bartolozzi (2002) ArticleTitleTissue harmonic and contrast-specific imaging: back to gray scale in ultrasound Eur Radiol 12 151–165 Occurrence Handle11868093 Occurrence Handle10.1007/s003300101022
H Ding M Kudo H Onda et al. (2001) ArticleTitleEvaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT Radiology 221 721–730 Occurrence Handle11719668 Occurrence Handle1:STN:280:DC%2BD3MnntlOqtw%3D%3D
M Matsuo M Kanematsu Y Inaba et al. (2001) ArticleTitlePre-operative detection of malignant hepatic tumours: value of combined helical CT during arterial portography and biphasic CT during hepatic arteriography Clin Radiol 56 138–145 Occurrence Handle11222073 Occurrence Handle1:STN:280:DC%2BD3M7otlarsw%3D%3D Occurrence Handle10.1053/crad.2000.0593
GA Krinsky VS Lee ND Theise et al. (2001) ArticleTitleHepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation Radiology 219 445–454 Occurrence Handle11323471 Occurrence Handle1:STN:280:DC%2BD3M3mt1eisg%3D%3D
Y Imai T Murakami S Yoshida et al. (2000) ArticleTitleSuperparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading Hepatology 32 205–212 Occurrence Handle10915725 Occurrence Handle1:STN:280:DC%2BD3cvgsVWntA%3D%3D Occurrence Handle10.1053/jhep.2000.9113
MJ Tong LM Blatt VW Kao (2001) ArticleTitleSurveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America J Gastroenterol Hepatol 16 553–559 Occurrence Handle11350553 Occurrence Handle1:STN:280:DC%2BD3M3lt1KhtA%3D%3D Occurrence Handle10.1046/j.1440-1746.2001.02470.x
YC Peng CS Chan GH Chen (1999) ArticleTitleThe effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma Hepatogastroenterology 46 3208–3211 Occurrence Handle10626187 Occurrence Handle1:STN:280:DC%2BD3c%2FptFKgsA%3D%3D
MH Nguyen RT Garcia PW Simpson et al. (2002) ArticleTitleRacial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis Hepatology 36 410–417 Occurrence Handle12143050 Occurrence Handle1:CAS:528:DC%2BD38XmsVansLo%3D Occurrence Handle10.1053/jhep.2002.34744
F Trevisani PE D'Intino AM Morselli-Labate et al. (2001) ArticleTitleSerum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 570–575 Occurrence Handle11394657 Occurrence Handle1:STN:280:DC%2BD3Mzis1Gisw%3D%3D Occurrence Handle10.1016/S0168-8278(00)00053-2
K Shiraki K Takase Y Tameda et al. (1995) ArticleTitleA clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients Hepatology 22 802–807 Occurrence Handle7544756 Occurrence Handle1:CAS:528:DyaK2MXoslarur8%3D Occurrence Handle10.1016/0270-9139(95)90300-3
MY Hsieh SN Lu LY Wang et al. (1992) ArticleTitleAlpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization J Gastroenterol Hepatol 7 614–617 Occurrence Handle1283085 Occurrence Handle1:STN:280:ByyC3snjslA%3D
F Nomura M Ishijima K Kuwa et al. (1999) ArticleTitleSerum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma Am J Gastroenterol 94 650–654 Occurrence Handle10086646 Occurrence Handle1:CAS:528:DyaK1MXitV2ku70%3D Occurrence Handle10.1111/j.1572-0241.1999.00930.x
JA Marrero GL Su W Wei et al. (2003) ArticleTitleDes-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients Hepatology 37 1114–1121 Occurrence Handle12717392 Occurrence Handle1:CAS:528:DC%2BD3sXktVWnsLs%3D Occurrence Handle10.1053/jhep.2003.50195
Y Aoyagi M Oguro M Yanagi et al. (1996) ArticleTitleClinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma Cancer 77 1781–1786 Occurrence Handle8646674 Occurrence Handle1:STN:280:BymB3cflslY%3D Occurrence Handle10.1002/(SICI)1097-0142(19960501)77:9<1781::AID-CNCR4>3.0.CO;2-F
Y Hippo K Watanabe A Watanabe et al. (2004) ArticleTitleIdentification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma Cancer Res 64 2418–2423 Occurrence Handle15059894 Occurrence Handle1:CAS:528:DC%2BD2cXis1yjtLY%3D Occurrence Handle10.1158/0008-5472.CAN-03-2191
MW Smith ZN Yue GK Geiss et al. (2003) ArticleTitleIdentification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma Cancer Res 63 859–864 Occurrence Handle12591738 Occurrence Handle1:CAS:528:DC%2BD3sXht1GqsLs%3D
M Chuma M Sakamoto K Yamazaki et al. (2003) ArticleTitleExpression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma Hepatology 37 198–207 Occurrence Handle12500205 Occurrence Handle1:CAS:528:DC%2BD3sXovVWhuw%3D%3D Occurrence Handle10.1053/jhep.2003.50022
M Takashima Y Kuramitsu Y Yokoyama et al. (2003) ArticleTitleProteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma Proteomics 3 2487–2493 Occurrence Handle14673798 Occurrence Handle1:CAS:528:DC%2BD2cXhvVSh Occurrence Handle10.1002/pmic.200300621
FL Green DL Page ID Fleming et al. (2002) Liver (Including Intrahepatic Bile Duct) FL Green (Eds) et al. AJCC cancer staging manual EditionNumber6th edn Springer Chicago 131–144
K Okuda T Ohtsuki H Obata et al. (1985) ArticleTitleNatural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918–928 Occurrence Handle2990661 Occurrence Handle1:STN:280:BiqB2MvivFE%3D
InstitutionalAuthorNameThe Cancer of the Liver Italian Program (Clip) Investigators (1998) ArticleTitleA new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 751–755 Occurrence Handle10.1002/hep.510280322
JM Llovet C Bru J Bruix (1999) ArticleTitlePrognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329–338 Occurrence Handle10518312 Occurrence Handle1:STN:280:DyaK1Mvks1Grsg%3D%3D Occurrence Handle10.1055/s-2007-1007122
M Kudo H Chung S Haji et al. (2004) ArticleTitleValidation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score Hepatology 40 1396–1405 Occurrence Handle15565571 Occurrence Handle10.1002/hep.20486
R Tateishi H Yoshida S Shiina et al. (2005) ArticleTitleProposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 419–425 Occurrence Handle15710994 Occurrence Handle1:STN:280:DC%2BD2M%2FotFKjtg%3D%3D Occurrence Handle10.1136/gut.2003.035055
J Bruix M Sherman JM Llovet et al. (2001) ArticleTitleClinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421–430 Occurrence Handle11592607 Occurrence Handle1:STN:280:DC%2BD3MrksFCmtg%3D%3D Occurrence Handle10.1016/S0168-8278(01)00130-1
TJ Song EW Ip Y Fong (2004) ArticleTitleHepatocellular carcinoma: current surgical management Gastroenterology 127 S248–260 Occurrence Handle15508091 Occurrence Handle10.1053/j.gastro.2004.09.039
G Ercolani GL Grazi M Ravaioli et al. (2003) ArticleTitleLiver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 536–543 Occurrence Handle12677151 Occurrence Handle10.1097/00000658-200304000-00016
RTP Poon ST Fan J Wong (2000) ArticleTitleRisk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma Ann Surg 232 10–24
JM Llovet J Fuster J Bruix (1999) ArticleTitleIntention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1434–1440 Occurrence Handle10573522 Occurrence Handle1:STN:280:DC%2BD3c%2Fkt1eiug%3D%3D Occurrence Handle10.1002/hep.510300629
S Rossi M Di Stasi E Buscarini et al. (1996) ArticleTitlePercutaneous RF interstitial thermal ablation in the treatment of hepatic cancer AJR Am J Roentgenol 167 759–768 Occurrence Handle8751696 Occurrence Handle1:STN:280:BymA2M%2FgsFQ%3D
L Buscarini E Buscarini M Di Stasi et al. (2001) ArticleTitlePercutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results Eur Radiol 11 914–921 Occurrence Handle11419162 Occurrence Handle1:STN:280:DC%2BD38%2FhsVemuw%3D%3D Occurrence Handle10.1007/s003300000659
S Shiina T Teratani S Obi et al. (2005) ArticleTitleA randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 122–130 Occurrence Handle16012942 Occurrence Handle10.1053/j.gastro.2005.04.009
M Akamatsu H Yoshida S Obi et al. (2004) ArticleTitleEvaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial Liver Int 24 625–629 Occurrence Handle15566514 Occurrence Handle10.1111/j.1478-3231.2004.0963.x
JM Llovet J Bruix (2003) ArticleTitleSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429–442 Occurrence Handle12540794 Occurrence Handle1:CAS:528:DC%2BD3sXhsFeltrg%3D Occurrence Handle10.1053/jhep.2003.50047
T Chiba K Tokuuye Y Matsuzaki et al. (2005) ArticleTitleProton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients Clin Cancer Res 11 3799–3805 Occurrence Handle15897579
JF Geschwind R Salem BI Carr et al. (2004) ArticleTitleYttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 S194–205 Occurrence Handle15508085 Occurrence Handle1:CAS:528:DC%2BD2cXhtVGmtbzN Occurrence Handle10.1053/j.gastro.2004.09.034
AG Visioli IH Rivens GR ter Haar et al. (1999) ArticleTitlePreliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours Eur J Ultrasound 9 11–18 Occurrence Handle10099162 Occurrence Handle1:STN:280:DyaK1M3gtFCqug%3D%3D Occurrence Handle10.1016/S0929-8266(99)00009-9
MH Chang CJ Chen MS Lai et al. (1997) ArticleTitleUniversal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1855–1859 Occurrence Handle9197213 Occurrence Handle1:STN:280:ByiA38vgs1U%3D Occurrence Handle10.1056/NEJM199706263362602
SM Lin IS Sheen RN Chien et al. (1999) ArticleTitleLong-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 29 971–975 Occurrence Handle10051505 Occurrence Handle1:CAS:528:DyaK1MXhvFyjsb8%3D Occurrence Handle10.1002/hep.510290312
A Matsumoto E Tanaka A Rokuhara et al. (2005) ArticleTitleEfficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients Hepatol Res 32 173–184 Occurrence Handle1:CAS:528:DC%2BD2MXmvVCmsbo%3D Occurrence Handle16024289
M Omata Y Shiratori (2000) ArticleTitleLong-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C J Gastroenterol Hepatol 15 IssueIDSuppl E134–140 Occurrence Handle10921397 Occurrence Handle1:CAS:528:DC%2BD3cXltFOjtrw%3D Occurrence Handle10.1046/j.1440-1746.2000.02115.x
S Nishiguchi T Kuroki S Nakatani et al. (1995) ArticleTitleRandomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1051–1055 Occurrence Handle7564784 Occurrence Handle1:CAS:528:DyaK2MXpsl2lurY%3D Occurrence Handle10.1016/S0140-6736(95)91739-X
InstitutionalAuthorNameInternational interferon-alpha hepatocellular carcinoma study group (1998) ArticleTitleEffect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study Lancet 351 1535–1539
Y Arase K Ikeda N Murashima et al. (1997) ArticleTitleThe long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1494–1500 Occurrence Handle9118029 Occurrence Handle1:CAS:528:DyaK2sXislamsbc%3D Occurrence Handle10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B
Y Muto H Moriwaki M Ninomiya et al. (1996) ArticleTitlePrevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group N Engl J Med 334 1561–1567 Occurrence Handle8628336 Occurrence Handle1:CAS:528:DyaK28XksVCgsLk%3D Occurrence Handle10.1056/NEJM199606133342402
InstitutionalAuthorNameInternational Union Against Cancer (UICC) (2002) Liver LH Sobin CH Wittekind (Eds) TNM Classification of Malignant tumours EditionNumber6th ed. Wiley-Liss New York 81–83
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yoshida, H., Yoshida, H., Shiina, S. et al. Early liver cancer: concepts, diagnosis, and management. Int J Clin Oncol 10, 384–390 (2005). https://doi.org/10.1007/s10147-005-0537-2
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10147-005-0537-2